Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Chronic Kidney Disease III: Interprofessional Care

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...

Heart Failure Drugs: Diuretics

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...

Factors Affecting Renal Clearance: Renal Impairment

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Some Points in the Application of Hydrochlorate of Cocaine to Dental Surgery.

The Independent practitioner·2023

Same author

Ethnic differences in complement system biomarkers and their association with metabolic health in men of Black African and White European ethnicity.

Clinical and experimental immunology·2023

Same author

The rare C9 P167S risk variant for age-related macular degeneration increases polymerization of the terminal component of the complement cascade.

Human molecular genetics·2021

Same author

Growth, tolerance, and DHA and ARA status of healthy term infants receiving formula with two different ARA concentrations: Double-blind, randomized, controlled trial.

Prostaglandins, leukotrienes, and essential fatty acids·2019

Same author

A triglyceride-rich lipoprotein environment exacerbates renal injury in the accelerated nephrotoxic nephritis model.

Clinical and experimental immunology·2018

Same author

Thrombomodulin enhances complement regulation through strong affinity interactions with factor H and C3b-Factor H complex.

Thrombosis research·2016

Search research articles

Related Experiment Video

Updated: Jun 28, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

Complement, roles in renal disease and modulation for therapy.

N J Hepburn¹, M M Ruseva, C L Harris

¹Department of Medical Biochemistry and Immunology, School of Medicine, Cardiff University, Heath Park, Cardiff, UK. hepburnnj@cardiff.ac.uk

Clinical Nephrology

|November 13, 2008

Summary

This summary is machine-generated.

The complement system is crucial for immunity but can cause disease when dysregulated. Targeting complement, especially with anti-C5 therapies, shows promise for treating renal and other inflammatory conditions.

Related Experiment Videos

Last Updated: Jun 28, 2026

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats

Published on: April 4, 2025

Area of Science:

Immunology
Pathology

Background:

The complement system is vital for innate immunity, pathogen defense, and immune response regulation.
Host protection relies on complement regulatory proteins, but dysregulation links complement to various diseases.
Inappropriate complement activation is implicated in renal pathologies and extrarenal conditions like PNH, AMD, and liver fibrosis.

Purpose of the Study:

To review the role of the complement system in renal pathologies.
To examine complement's involvement in paroxysmal nocturnal hemoglobinuria, age-related macular degeneration, and liver fibrosis.
To discuss complement as a therapeutic target in disease.

Main Methods:

Literature review focusing on complement's role in disease.
Analysis of evidence linking complement regulators and components to disease susceptibility.
Discussion of therapeutic strategies targeting the complement system.

Main Results:

Mutations or polymorphisms in complement regulators increase disease susceptibility, particularly kidney vulnerability.
Complement component deficiencies can lead to disease via impaired apoptotic cell clearance and autoantibody formation.
The complement system is a validated therapeutic target in various disease contexts.

Conclusions:

Dysregulation of the complement system significantly contributes to renal and extrarenal pathologies.
Therapeutic strategies, particularly anti-C5 antibody-derived reagents, are effective for treating complement-mediated diseases.
Targeting complement offers a promising avenue for managing renal pathologies and other inflammatory conditions.